| EMA number | EMEA/H/C/005675 |
| ATC code | J07BN02 |
| Authorisation | 29 January 2021 |
| Withdrawn | 27 March 2024 |
| Revision | 32 |
Vaxzevria is indicated for active immunisation to prevent COVID 19 caused by SARS CoV 2, in individuals 18 years of age and older. The use of this vaccine should be in accordance with official recommendations.